Psilocybin trials for healthy volunteers
13 recruiting now and 2 not yet recruiting, grouped by the conditions each study lists on ClinicalTrials.gov, read 28 October 2026. Recruiting trials are listed first.
- RecruitingPhase 1 / Phase 2NCT05301608
Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought
Healthy · Johns Hopkins University · Ages 18 to 75
Baltimore, Maryland, United States
- RecruitingPhase 1NCT05866471
The ENHANCE Study: taVNS and Psilocybin
Healthy, Psychedelic Experiences, Vagus Nerve Stimulation · University of Wisconsin, Madison · Ages 18 to 70
Madison, Wisconsin, United States
- RecruitingPhase 2NCT06626139
Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers
Healthy Participants With Lower-than-average Mental Well-being · Robin Carhart-Harris, PhD, MA · Ages 21 to 70
San Francisco, California, United States
- RecruitingPhase 1NCT06772753
Investigation of Psychedelic Effects in Psychoactive Substances
Psychedelic Effects in Healthy Volunteers · Johns Hopkins University · Ages 25 to 55
Baltimore, Maryland, United States
- RecruitingPhase 1NCT06796361
Role of the Serotonin 2A Receptor in Psilocybin-induced Altered States of Consciousness
Healthy · University Hospital, Basel, Switzerland · Ages 25 to 75
Basel, Canton of Basel-City, Switzerland
- RecruitingPhase 1NCT06815653
Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs
Healthy · University College, London · Ages 21 to 65
London, United Kingdom
- RecruitingPhase 1NCT06899334
Direct Comparison of Altered States of Consciousness Induced by LSD, Psilocybin, and DMT in Healthy Participants
Healthy · University Hospital, Basel, Switzerland · Ages 25+
Basel, Switzerland
- RecruitingPhase 1NCT07079930
Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers
Healthy Volunteers · Hadassah Medical Organization · Ages 25 to 60
Jerusalem, Israel
- RecruitingPhase 1NCT07386730
A Study of Psychedelics in Healthy Older Adults With Low Well-being
Anhedonia in Healthy Volunteers, Older Adults (50-90 Years) · Jennifer Mitchell · Ages 50 to 85
San Francisco, California, United States
- RecruitingPhase 1NCT07516405
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
Healthy Volunteer, Older Adults (65-85 Years) · University of Colorado, Denver · Ages 65 to 85
6 sites in United States
- RecruitingEarly phase 1NCT07565493
Psilocybin Administration With 5-HT1a Blockade
Psychedelic Effects in Healthy Volunteers · Johns Hopkins University · Ages 21 to 60
Baltimore, Maryland, United States
- RecruitingPhase 1 / Phase 2NCT07610135
Psilocybin Efficacy With or Without Pimavanserin Pretreatment
Mood (Psychological Function), Well Being, Mood · Johns Hopkins University · Ages 21 to 65
Baltimore, Maryland, United States
- RecruitingEarly phase 1NCT07732166
Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.
Healthy Adults · Pontifícia Universidade Católica do Rio de Janeiro · Ages 21 to 60
Rio de Janeiro, Rio de Janeiro, Brazil
- Not yet recruitingPhase 1 / Phase 2NCT07079852
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
Healthy · Manoj Doss · Ages 21 to 45
Austin, Texas, United States
- Not yet recruitingPhase 1NCT07433452
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.
Healthy Participants, Placebo - Control, Psilocybin · Gabriella Gobbi · Ages 21 to 65
Sites not yet listed
How joining a trial works
- Free to take part
- Trials generally cost participants nothing for the study drug and the study visits, and some pay for travel or time. Check what a study covers on its registry page.
- Screened first
- Every study screens volunteers with questionnaires, medical history and often a physical and psychiatric check. Many people who apply are not enrolled.
- Eligibility is strict
- Common exclusions include a personal or family history of psychosis or bipolar disorder, some heart conditions, pregnancy and certain medications, which you may be asked to stop under medical supervision. Never stop a medication on your own to qualify.
- You may get a placebo
- Many trials compare psilocybin with a placebo or a low dose, and you may not be told which you had until the study ends.
- Contact the study team through the registry
- Each registry record lists the study contacts and sites. We do not republish personal emails or phone numbers; use the link on each trial page.
- Not medical advice
- This is a list of registry records, not a recommendation. Talk to your doctor before applying. Disclaimer · Safety and medications
Source: ClinicalTrials.gov API v2, U.S. National Library of Medicine, read 28 October 2026. Filter: overall status RECRUITING or NOT_YET_RECRUITING; an intervention named psilocybin, psilocin, COMP360 or CYB003. Refreshed weekly; a study's own registry page is always the current record.